Insider · CIK 0001998937
Timothy John Garnett
Files at MPLT (MapLight Therapeutics, Inc.). First filing Feb 12, 2026, latest Feb 12, 2026.
In brief
Timothy John Garnett files SEC Form 4 as director at MPLT (MapLight Therapeutics, Inc.). Since Feb 12, 2026, Timothy John Garnett has reported 1 open-market buy worth $253k and 0 open-market sells worth $0, the latest filed on Feb 12, 2026.
A track record needs three past buys with six months of prices behind them; Timothy John Garnett has 0, so none is measured yet.
The newest scored trade: bought $253k of MPLT on Feb 10, 2026, filed Feb 12, 2026, scored 48 (moderate). In the last 12 months: 1 buy worth $253k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MPLT: MapLight Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | MapLight Therapeutics, Inc. | $253k 14,124 shares | - | +40% from low-15% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +3,932 | $0.00 | $0 | 53,457 | Jun 25, 2026 |
| Jun 23, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,902 | $0.00 | $0 | 14,902 | Jun 25, 2026 |
| Feb 10, 2026 | MPLT MapLight Therapeutics, Inc. | POpen-market purchase Voting Common Stockindirect: See footnote | +14,124 | $17.89 | $253k | 14,124 | Feb 12, 2026 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +6,294 | $0.00 | $0 | 6,294 | Oct 28, 2025 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +25,604 | $0.00 | $0 | 25,604 | Oct 28, 2025 |
Questions about Timothy John Garnett
Answered from the filings on this page, as of the latest one.
Is Timothy John Garnett buying or selling?
In the last 12 months Timothy John Garnett reported 1 open-market buy worth $253k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $253k of MPLT on Feb 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Timothy John Garnett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy John Garnett has 0.
Where does Timothy John Garnett file Form 4?
Timothy John Garnett has filed Form 4 at MPLT (MapLight Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.